HIMS NYSE
Hims & Hers Health, Inc.
1W: -0.9%
1M: -17.2%
3M: +53.6%
YTD: -28.1%
1Y: -60.8%
3Y: +129.1%
5Y: +171.6%
$23.75
-0.26 (-1.08%)
After Hours: $23.72 (-0.03, -0.13%)
Weekly Expected Move ±12.7%
$19
$22
$25
$28
$31
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.10
Neutral
4 bullish
2 neutral
3 bearish
Articles (7d)
9
Daily Sentiment (7 Days)
Articles (100)
Hims & Hers Deepens Personalized Care Through Platform Expansion
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
The Silver Lining of Last Week's Hims & Hers Earnings Miss
Hims & Hers Stock Slips As Dilution Fears Outweigh New Capital
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Hims & Hers Massive Stock Drop Explained
Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering
Why Is Hims & Hers Stock Sinking Monday?
$1000 Invested In Hims & Hers Health 5 Years Ago Would Be Worth This Much Today
DOCS vs. HIMS: Which Stock Is the Better Value Option?
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
Is Hims and Hers Health Stock a Buy After Its Latest Dip?
Company News for May 13, 2026
Nasdaq 100 Dips On Hot CPI, Sandisk And Micron Tumble 9%: Stock Market Today
Hims & Hers Health Posts Mixed Q1 Amid Weight-Loss Product 'Noise': Analysts
Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down
Why Hims & Hers Health Stock Just Crashed
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
Hims & Hers Health, Inc. Q1 2026 Earnings Call Summary
Why Is Hims & Hers Stock Sinking Tuesday?
AST SpaceMobile Posts Downbeat Q1 Results, Joins Hims & Hers Health, Gitlab And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Biggest stock movers Tuesday: PLUG, HIMS, and more
Hims & Hers forecasts $2.8B-$3.0B 2026 revenue as it targets 100,000+ monthly weight loss subscriber adds
Hims HIMS Q1 2026 Earnings Call Transcript
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Misses Revenue Estimates
$HIMS - Earnings Report
HIMS Earnings: Hims & Hers Stock Falls 10% as Financial Results Miss Wall Street Targets - TipRanks
Why Hims & Hers Health Are Falling Monday
Hims & Hers Expands Digital Healthcare Platform via New Care Offerings
Why Is Hims & Hers Health Stock Trading Higher On Monday?
Markets Await Key Inflation Data This Week
Inflation Numbers Out This Week: CPI, PPI
Stock Market Today: S&P 500, Dow Futures Fall As Trump Rejects 'Totally Unacceptable' Iran Peace Proposal—Micron Technologies, Moderna In Focus
Earnings week ahead: BABA, CSCO, PLUG, AMAT, JD, and more
Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
Gambling my 401k/Roth from 10k -> $2M ($DOCN & others)
Novo Nordisk earnings seen as inflection point amid GLP-1 pricing reset
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
Most and least shorted stocks over $2B market cap
If You Invested $1000 In Hims & Hers Health Stock 5 Years Ago, You Would Have This Much Today
Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Most and least shorted mid-to mega-cap healthcare stocks in May
Organon & Co is the best performing healthcare stock in April
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
EXCLUSIVE: Enhanced CEO Says Its Performance Medicine Platform Is The Real Prize Beyond The Games
Hims & Hers Expands Digital-First Access to Personalized Healthcare
Hims & Hers Health, Inc. (HIMS) is a Top-Ranked Momentum Stock: Should You Buy?
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
BrightSpring Before Q1 Earnings: Buy, Sell or Hold the Stock Now?
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
SpaceX Goes on $60 Billion AI Buying Spree
Baxter Q1 Preview: Will Operational Headwinds Weigh on Results Again?
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Sandisk and Whirlpool have been highlighted as Zacks Bull and Bear of the Day
Tempus AI Nears Profitability as Operating Leverage Emerges
Hims rises as J.P. Morgan initiates at Overweight on rich catalyst path
Biggest stock movers Friday: MXL, INTC, COUR, CHTR, MXL, and more
This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Hims & Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch
Why Hims & Hers Health, Inc. (HIMS) is a Top Growth Stock for the Long-Term
Hims & Hers doubles down on estrogen patches as demand surges
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program
Amazon GLP-1 Program Pressures Hims & Hers Stock
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform
Best-Performing Leveraged ETFs of Last Week
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
Why Hims & Hers Health Stock Is Surging Monday
Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday
Trending stocks this week as markets hit new highs while Middle East tensions persist
Most shorted mid cap stocks as of mid-April
SA analyst upgrades/downgrades: NVDA, VZ, MRVL, HIMS
What's Going On With Hims & Hers Shares
GLP-1 trials show mood improvement rather than the ‘Ozempic personality’ – Dr. Angela Fitch
Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?
Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies
Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?
Biggest stock movers Thursday: AEHR, ABT, HOOD, COIN, and more
HIMS Plunges 51.2% in 6 Months: Should You Still Hold the Stock or Sell?
FDA To Review Easing Grip On Several Peptide Therapies Popular Among Influencers And Fitness Gurus In Potential Win For RFK Jr.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why Is Hims & Hers Stock Soaring After FDA's Announcment?
Allbirds, Hims & Hers, Microsoft, Xanadu Quantum And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Here's How Much $1000 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms
Hims & Hers Health, Inc. $HIMS Shares Sold by Carnegie Investment Counsel
Did Hims & Hers Just Become an AI Company?